| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0574-0791-01 | 0574-0791 | HUMAN PRESCRIPTION DRUG | methazolamide | methazolamide | TABLET | ORAL | 20140930 | 20260831 | ANDA | ANDA040062 | Padagis US LLC | METHAZOLAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE, PLASTIC (0574-0791-01) |
| 0574-0790-01 | 0574-0790 | HUMAN PRESCRIPTION DRUG | methazolamide | methazolamide | TABLET | ORAL | 20140930 | 20270930 | ANDA | ANDA040062 | Padagis US LLC | METHAZOLAMIDE | 25 mg/1 | 100 TABLET in 1 BOTTLE, PLASTIC (0574-0790-01) |
| 55806-020-03 | 55806-020 | HUMAN PRESCRIPTION DRUG | methazolamide | methazolamide | TABLET | ORAL | 19940718 | 20250531 | ANDA | ANDA040062 | Effcon Laboratories, Inc. | METHAZOLAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE, PLASTIC (55806-020-03) |